Literature DB >> 28404852

Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.

Huahao Fan1,2, Luhua Qiao1,2, Kyung-Don Kang2, Junfen Fan2, Wensheng Wei3, Guangxiang Luo4,2.   

Abstract

Hepatitis C virus (HCV) requires multiple receptors for its attachment to and entry into cells. Our previous studies found that human syndecan-1 (SDC-1), SDC-2, and T cell immunoglobulin and mucin domain-containing protein 1 (TIM-1) are HCV attachment receptors. Other cell surface molecules, such as CD81, Claudin-1 (CLDN1), Occludin (OCLN), SR-BI, and low-density lipoprotein receptor (LDLR), function mainly at postattachment steps and are considered postattachment receptors. The underlying molecular mechanisms of different receptors in HCV cell-free and cell-to-cell transmission remain elusive. In the present study, we used a clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 technology, gene-specific small interfering RNAs, and a newly developed luciferase-based reporter system to quantitatively determine the importance of individual receptors in HCV cell-free and cell-to-cell transmission. Knockouts of SDC-1 and SDC-2 resulted in remarkable reductions of HCV infection and cell attachment, whereas SDC-3 and SDC-4 knockouts did not affect HCV infection. Defective HCV attachment to SDC-1 and/or SDC-2 knockout cells was completely restored by SDC-1 and SDC-2 but not SDC-4 expression. Knockout of the attachment receptors SDC-1, SDC-2, and TIM-1 also modestly decreased HCV cell-to-cell transmission. In contrast, silencing and knockout of the postattachment receptors CD81, CLDN1, OCLN, SR-BI, and LDLR greatly impaired both HCV cell-free and cell-to-cell transmission. Additionally, apolipoprotein E was found to be important for HCV cell-to-cell spread, but very-low-density lipoprotein (VLDL)-containing mouse serum did not affect HCV cell-to-cell transmission, although it inhibited cell-free infection. These findings demonstrate that attachment receptors are essential for initial HCV binding and that postattachment receptors are important for both HCV cell-free and cell-to-cell transmission.IMPORTANCE The importance and underlying molecular mechanisms of cell surface receptors in HCV cell-free and cell-to-cell transmission are poorly understood. The role of some of the HCV attachment and postattachment receptors in HCV infection and cell-to-cell spread remains controversial. Using CRISPR-Cas9-mediated knockouts of specific cellular genes, we demonstrate that both SDC-1 and SDC-2, but not SDC-3 or SDC-4, are bona fide HCV attachment receptors. We also used a newly developed luciferase-based reporter system to quantitatively determine the importance of attachment and postattachment receptors in HCV cell-to-cell transmission. SDC-1, SDC-2, TIM-1, and SR-BI were found to modestly promote HCV cell-to-cell spread. CD81, CLDN1, OCLN, and LDLR play more important roles in HCV cell-to-cell transmission. Likewise, apolipoprotein E (apoE) is critically important for HCV cell-to-cell spread, unlike VLDL-containing mouse serum, which did not affect HCV cell-to-cell spread. These findings suggest that the mechanism(s) of HCV cell-to-cell spread differs from that of cell-free infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  attachment receptor; cell-free infection; cell-to-cell transmission; hepatitis C virus; infection; postattachment receptor

Mesh:

Substances:

Year:  2017        PMID: 28404852      PMCID: PMC5469255          DOI: 10.1128/JVI.00280-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Authors:  Shufeng Liu; Kevin D McCormick; Wentao Zhao; Ting Zhao; Daping Fan; Tianyi Wang
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

2.  Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.

Authors:  Zhe Liu; Yongjun Tian; Keigo Machida; Michael M C Lai; Guangxiang Luo; Steven K H Foung; Jing-hsiung James Ou
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

3.  The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.

Authors:  Kenichi Morikawa; Zijiang Zhao; Tomoko Date; Michiko Miyamoto; Asako Murayama; Daisuke Akazawa; Junichi Tanabe; Saburo Sone; Takaji Wakita
Journal:  J Med Virol       Date:  2007-06       Impact factor: 2.327

Review 4.  Hepatitis C virus entry into host cells.

Authors:  F Helle; J Dubuisson
Journal:  Cell Mol Life Sci       Date:  2008-01       Impact factor: 9.261

5.  Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.

Authors:  Kyung-Soo Chang; Jieyun Jiang; Zhaohui Cai; Guangxiang Luo
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.

Authors:  Muhammad N Zahid; Marine Turek; Fei Xiao; Viet Loan Dao Thi; Maryse Guérin; Isabel Fofana; Philippe Bachellier; John Thompson; Leen Delang; Johan Neyts; Dorothea Bankwitz; Thomas Pietschmann; Marlène Dreux; François-Loïc Cosset; Fritz Grunert; Thomas F Baumert; Mirjam B Zeisel
Journal:  Hepatology       Date:  2012-12-28       Impact factor: 17.425

7.  Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.

Authors:  Zhen-yong Keck; Jinming Xia; Yong Wang; Wenyan Wang; Thomas Krey; Jannick Prentoe; Thomas Carlsen; Angela Ying-Jian Li; Arvind H Patel; Stanley M Lemon; Jens Bukh; Felix A Rey; Steven K H Foung
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

8.  Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.

Authors:  Terence N Bukong; Fatemeh Momen-Heravi; Karen Kodys; Shashi Bala; Gyongyi Szabo
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

9.  Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies.

Authors:  Joe Grove; Søren Nielsen; Jin Zhong; Margaret F Bassendine; Heidi E Drummer; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.

Authors:  Zhen-Yong Keck; Jinming Xia; Zhaohui Cai; Ta-Kai Li; Ania M Owsianka; Arvind H Patel; Guangxiang Luo; Steven K H Foung
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more
  12 in total

Review 1.  Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.

Authors:  Jannick Prentoe; Jens Bukh
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

2.  Building a mechanistic mathematical model of hepatitis C virus entry.

Authors:  Mphatso Kalemera; Dilyana Mincheva; Joe Grove; Christopher J R Illingworth
Journal:  PLoS Comput Biol       Date:  2019-03-18       Impact factor: 4.475

Review 3.  Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets.

Authors:  Nathalie Alazard-Dany; Solène Denolly; Bertrand Boson; François-Loïc Cosset
Journal:  Viruses       Date:  2019-01-06       Impact factor: 5.048

4.  Human apolipoprotein E promotes hepatitis B virus infection and production.

Authors:  Luhua Qiao; Guangxiang George Luo
Journal:  PLoS Pathog       Date:  2019-08-08       Impact factor: 6.823

Review 5.  Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men.

Authors:  Bernadien M Nijmeijer; Jelle Koopsen; Janke Schinkel; Maria Prins; Teunis Bh Geijtenbeek
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

6.  Viral cell-to-cell spread: Conventional and non-conventional ways.

Authors:  Nicolas Cifuentes-Munoz; Farah El Najjar; Rebecca Ellis Dutch
Journal:  Adv Virus Res       Date:  2020-09-29       Impact factor: 9.937

Review 7.  Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies.

Authors:  Emmanuelle V LeBlanc; Youjin Kim; Chantelle J Capicciotti; Che C Colpitts
Journal:  Pathogens       Date:  2021-06-01

Review 8.  Hepatitis C virus infection and tight junction proteins: The ties that bind.

Authors:  Laurent Mailly; Thomas F Baumert
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-04-05       Impact factor: 4.019

9.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.

Authors:  Hua-Hao Fan; Li-Qin Wang; Wen-Li Liu; Xiao-Ping An; Zhen-Dong Liu; Xiao-Qi He; Li-Hua Song; Yi-Gang Tong
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

Review 10.  The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle.

Authors:  Rasika D Kunden; Juveriya Q Khan; Sarah Ghezelbash; Joyce A Wilson
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.